MAPT and Alzheimer disease: It has been found that a range of protein kinases contributes to the progression of AD by phosphorylating tau in vitro, among the physiologically relevant proteins, glycogen synthase kinase-3β (GSK-3β) appears to be one of the targets of alsterpaullone (Leost et al., 2000).